None listed
Conditions
Brief summary
The patients with malignant obstructive jaundice in advanced disease have poor quality of life according the results of literature review and clinical observations, so the main purpose of this study is the use of the QLQ-C30 scale developed by the European cancer research and treatment organizations, and the group pre-developed in patients with malignant obstructive jaundice specific item pool (QLQ-MOJ11) the class of the patient's quality of life evaluation, and analysis of these patients the survival time and the risk factors for death during hospitalization and late follow-up results, the trend of quality of life drawing class for patients with different treatment methods.
Interventions
1.Our research group have developed the quality of life scale specific module about malignant obstructive jaundice patients (QLQ-MOJ11) on the basis of EORTC QLQ-C30 scale. So we apply both EORTC QLQ-C30 and QLQ-MOJ11 scale to evaluation the quality of life for patients with malignant obstructive jaundice from admission to three months discharge. The patiernts need to fill with the scale five times over this period. We use the methods of self-evaluation and telephone follow-up to assesment th
1.Our research group have developed the quality of life scale specific module about malignant obstructive jaundice patients (QLQ-MOJ11) on the basis of EORTC QLQ-C30 scale. So we apply both EORTC QLQ-C30 and QLQ-MOJ11 scale to evaluation the quality of life for patients with malignant obstructive jaundice from admission to three months discharge. The patiernts need to fill with the scale five times over this period. We use the methods of self-evaluation and telephone follow-up to assesment the QOL of malignant obstructive jaundice patients. 2.The purpose of collecting general information on the patient is to judgment the demographic characteristics and biochemical indicators of the impact on patient quality of life and survival time. So that we can predict the risk factors with death forpatients with malignant obstructive jaundice .
Sponsors
Eastern Hepatobiliary Surgery Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1) clinically diagnosed with primary bile duct cancer, gallbladder cancer, duodenal cancer, pancreatic cancer, bile duct cancer and metastatic carcinoma. 2) Serum bilirubin Serum Bilirubin thelarger than or equal to 17.1micromol / L. 3) Imaging studies confirmed the biliary obstruction. 4) informed consent of patients.
Exclusion criteria
1) past and current mental illness patients and consolidation of the heart, lungs and other major disorders. 2) can not understand the contents of the questionnaire, and patients with language barrier. 3) have been involved in the survey of patients.
Outcome results
None listed